substance p has been researched along with Acquired Meningomyelocele in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lister, J; Tam, PK | 2 |
| Kondo, A; Ohmura, M; Saito, M | 1 |
| Burnstock, G; Chapple, CR; Crowe, R; Light, JK; Moss, HE | 1 |
4 other study(ies) available for substance p and Acquired Meningomyelocele
| Article | Year |
|---|---|
Elevation of cerebrospinal fluid substance P concentrations in spina bifida.
Topics: Female; Gestational Age; Humans; Infant, Newborn; Meningomyelocele; Pregnancy; Radioimmunoassay; Spina Bifida Occulta; Substance P | 1984 |
Response of isolated human neurogenic bladders to tachykinins.
Topics: Adolescent; Atropine; Child; Dose-Response Relationship, Drug; Electric Stimulation; Female; Humans; In Vitro Techniques; Male; Meningomyelocele; Muscle Contraction; Neurokinin A; Neurokinin B; Sacrococcygeal Region; Substance P; Tachykinins; Urinary Bladder, Neurogenic | 1997 |
Patients with lower motor spinal cord lesion: a decrease of vasoactive intestinal polypeptide, calcitonin gene-related peptide and substance P, but not neuropeptide Y and somatostatin-immunoreactive nerves in the detrusor muscle of the bladder.
Topics: Adult; Calcitonin Gene-Related Peptide; Fluorescent Antibody Technique; Humans; Male; Meningomyelocele; Neuropeptide Y; Somatostatin; Substance P; Urinary Bladder; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Vasoactive Intestinal Peptide | 1991 |
Maldevelopment of spinal cord--substance P in spina bifida.
Topics: Female; Gestational Age; Humans; Meningomyelocele; Pregnancy; Spinal Cord; Substance P | 1986 |